Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Federal Circuit invalidates Sequenom patent, cites Mayo
Americas
A US appeals court has affirmed that a patent covering the method of detecting foetal abnormalities in pregnant mothers is ineligible for protection because it applies to a “natural phenomenon”.   17 June 2015
BIO 2015: Kicking off with a song and a dance
Americas
This year’s BIO International Convention in Philadelphia went off with a bang on Monday night as hundreds travelled to the kickoff concert to see three of the area’s most successful music acts of the last 50 years.   17 June 2015
Americas
US law firm Blank Rome has hired Paul Zagar as a partner to its intellectual property group.   17 June 2015
Americas
The pharmaceutical and biotechnology industries are in “very good shape” and the so-called patent cliff is “firmly in the rear view mirror”, according to a report by life sciences market research company Evaluate.   16 June 2015
Americas
The antibiotics market could lose out for a decade due to inadequate research and development in the area, according to a report published by UK law firm Marks & Clerk today, June 16.   16 June 2015
Americas
US law firm White and Williams has hired George Xixis as a counsel to its Boston office.   12 June 2015
Asia-Pacific
The High Court of Australia has revealed it will hear oral arguments in the patent dispute between breast cancer survivor Yvonne D’Arcy and molecular diagnostic company Myriad Genetics on June 16 and 17.   11 June 2015
Asia
Police in the Philippines have raided a call centre in Manila whose operators had allegedly been selling counterfeit drugs, including copies of Pfizer’s Viagra (sildenafil), over the phone.   10 June 2015
Americas
The US Court of Appeals for the Federal Circuit has sent a patent dispute between drugs companies Shire and Watson Pharmaceuticals back to a district court, ruling again that the lower court erroneously construed claims related to Lialda.   10 June 2015
Big Pharma
Pfizer has apologised to UK-based healthcare providers for any confusion or increased workload following the English High Court’s decision on a patent infringement case centring on its epilepsy drug Lyrica.   9 June 2015